Corina® Clinical Evidence Presented at SEUD Global Congress 2025

Corina® Clinical Evidence Presented at SEUD Global Congress 2025
Prague, Czech Republic | April 2025
In late April 2025, at the Global Congress on Endometriosis and Uterine Diseases (SEUD) held in Prague, Czech Republic, Professor Feng Limin from the Department of Obstetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University, presented the core clinical technology behind Corina® (Intrauterine Drug Eluting Stent) to an international audience of gynecology specialists.
Professor Feng highlighted Corina®’s key therapeutic concept: “localized estrogen delivery with safe and precise action.” By delivering medication directly to the uterine cavity, Corina® achieves enhanced endometrial regeneration with lower drug dosages, significantly reducing systemic exposure and minimizing the risk of hormone-related side effects.
This presentation demonstrated how targeted intrauterine therapy can overcome the limitations of conventional systemic treatment and represents an important advancement in the management of intrauterine diseases.